Laboratorios Farmacéuticos ROVI, S.A. S.A. is a fully-integrated, profitable, Spanish specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of small molecule and specialty biologic drugs.

Laboratorios Farmacéuticos ROVI, S.A. in line with its commitment to transparency and informative rigour presents this web section addressed to shareholders and investors, with the purpose to make available all information required by the ministerial decree ECC/461/2013 of March 20 and the Circular 3/2015 of June 23 of the CNMV, as well as all information available that the company will consider relevant about Corporate Governance's practices.


DateTitleContent
13/03/2017Otros sobre negocio y situación financieraThe Company releases the presentation related to its biosimilar of Enoxaparin
07/03/2017Otros sobre negocio y situación financieraROVI informs that the Decentralised procedure used for the registration of its biosimilar of enoxaparin has been completed with positive outcome
16/02/2017Información sobre resultadosROVI releases the press release related to the full year 2016 results
16/02/2017Información sobre resultadosROVI releases the presentation related to the full year 2016 results
16/02/2017Otros sobre Gobierno CorporativoThe Company informs about the agreements adopted by the Board of Directors